| The selectivity of protein kinase inhibitors: a further update J Bain, L Plater, M Elliott, N Shpiro, CJ Hastie, H Mclauchlan, I Klevernic, ... Biochemical Journal 408 (3), 297-315, 2007 | 3044 | 2007 |
| The specificities of protein kinase inhibitors: an update J Bain, H McLauchlan, M Elliott, P Cohen Biochemical Journal 371 (1), 199-204, 2003 | 1785 | 2003 |
| D4476, a cell‐permeant inhibitor of CK1, suppresses the site‐specific phosphorylation and nuclear exclusion of FOXO1a G Rena, J Bain, M Elliott, P Cohen EMBO reports 5 (1), 60-65, 2004 | 313 | 2004 |
| The selectivity of inhibitors of protein kinase CK2: an update MA Pagano, J Bain, Z Kazimierczuk, S Sarno, M Ruzzene, G Di Maira, ... Biochemical Journal 415 (3), 353-365, 2008 | 287 | 2008 |
| Optimization of protein kinase CK2 inhibitors derived from 4, 5, 6, 7-tetrabromobenzimidazole MA Pagano, M Andrzejewska, M Ruzzene, S Sarno, L Cesaro, J Bain, ... Journal of medicinal chemistry 47 (25), 6239-6247, 2004 | 224 | 2004 |
| A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research SJ Rihn, A Merits, S Bakshi, ML Turnbull, A Wickenhagen, AJT Alexander, ... PLoS biology 19 (2), e3001091, 2021 | 196 | 2021 |
| Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2 G Cozza, M Mazzorana, E Papinutto, J Bain, M Elliott, G Di Maira, ... Biochemical Journal 421 (3), 387-395, 2009 | 189 | 2009 |
| Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5, 6-dihydroindolo-(1, 2-a) quinazolin-7-yl] acetic acid (IQA) S Sarno, E de Moliner, M Ruzzene, MA Pagano, R Battistutta, J Bain, ... Biochemical journal 374 (3), 639-646, 2003 | 171 | 2003 |
| Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors MA Pagano, G Poletto, G Di Maira, G Cozza, M Ruzzene, S Sarno, J Bain, ... Chembiochem 8 (1), 129-139, 2007 | 144 | 2007 |
| Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition D Komander, GS Kular, J Bain, M Elliott, DR Alessi, DMF Van Aalten Biochemical Journal 375 (2), 255-262, 2003 | 143 | 2003 |
| ATP site-directed inhibitors of protein kinase CK2: an update S Sarno, E Papinutto, C Franchin, J Bain, M Elliott, F Meggio, ... Current topics in medicinal chemistry 11 (11), 1340-1351, 2011 | 121 | 2011 |
| Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study F Meggio, MA Pagano, S Moro, G Zagotto, M Ruzzene, S Sarno, G Cozza, ... Biochemistry 43 (40), 12931-12936, 2004 | 115 | 2004 |
| Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1 D Komander, GS Kular, AW Schüttelkopf, M Deak, KRC Prakash, J Bain, ... Structure 12 (2), 215-226, 2004 | 109 | 2004 |
| Comparison of the specificity of Trk inhibitors in recombinant and neuronal assays KJ Martin, N Shpiro, R Traynor, M Elliott, JSC Arthur Neuropharmacology 61 (1-2), 148-155, 2011 | 28 | 2011 |
| McLauchlan H, Elliott M, and Cohen P J Bain The specificities of protein kinase inhibitors: an update. Biochem J 371 …, 2003 | 22 | 2003 |
| Integrated multi-trophic aquaculture mitigates the effects of ocean acidification: Seaweeds raise system pH and improve growth of juvenile abalone SL Hamilton, MS Elliott, MS deVries, J Adelaars, MD Rintoul, MH Graham Aquaculture 560, 738571, 2022 | 17 | 2022 |
| 465 Arthur JSC, Alessi DR, Cohen P J Bain, L Plater, M Elliott, N Shpiro, CJ Hastie, H McLauchlan, I Klevernic The selectivity of protein kinase inhibitors: a 466, 297-315, 0 | 8 | |
| Multi-stakeholder cooperatives M Lund, S Novkovic Handbook of research on cooperatives and mutuals, 531-548, 2023 | 7 | 2023 |
| Nature of the farm: revisited M Elliott, HS James Agricultural and Resource Economics Review 46 (1), 123-145, 2017 | 5 | 2017 |
| Handbook of Research on Cooperatives and Mutuals MS Elliott, MA Boland Edward Elgar Publishing, 2023 | 3 | 2023 |
